Published in Front Neurosci on July 29, 2015
Endoplasmic reticulum stress and the unfolded protein response in disorders of myelinating glia. Brain Res (2016) 0.93
Harnessing the integrated stress response for the treatment of multiple sclerosis. Lancet Neurol (2016) 0.84
Dual role of the integrated stress response in medulloblastoma tumorigenesis. Oncotarget (2016) 0.75
Pharmacological inhibition of spinal cord injury-stimulated ribosomal biogenesis does not affect locomotor outcome. Neurosci Lett (2017) 0.75
Immunogenicity of self tumor associated proteins is enhanced through protein truncation. Mol Ther Oncolytics (2016) 0.75
NF-κB activation protects oligodendrocytes against inflammation. J Neurosci (2017) 0.75
Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature (1999) 16.97
The unfolded protein response: from stress pathway to homeostatic regulation. Science (2011) 15.71
An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell (2003) 15.12
Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev (1999) 13.24
NF-kappaB at the crossroads of life and death. Nat Immunol (2002) 12.98
CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev (2004) 9.24
Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol (2011) 8.75
The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol (2012) 8.52
A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science (2005) 7.98
Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J Cell Biol (2001) 7.82
Mechanisms underlying inflammation in neurodegeneration. Cell (2010) 7.66
From endoplasmic-reticulum stress to the inflammatory response. Nature (2008) 7.17
Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat Immunol (2003) 7.06
ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. Dev Cell (2002) 6.95
Multiple sclerosis--the plaque and its pathogenesis. N Engl J Med (2006) 6.60
Transcriptional and translational control in the Mammalian unfolded protein response. Annu Rev Cell Dev Biol (2002) 6.48
Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol (1996) 6.44
Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci (2008) 6.16
Endoplasmic reticulum stress signaling in disease. Physiol Rev (2006) 5.90
Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol (2004) 5.52
IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol (1996) 5.38
Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci (2008) 5.15
Autoimmune T cell responses in the central nervous system. Nat Rev Immunol (2009) 4.73
Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci Transl Med (2013) 4.62
The impact of the unfolded protein response on human disease. J Cell Biol (2012) 4.36
XBP1: a link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum. J Cell Biol (2004) 4.03
Cytoprotection by pre-emptive conditional phosphorylation of translation initiation factor 2. EMBO J (2004) 3.77
Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol (2002) 3.64
The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol (2001) 3.47
Targeting the unfolded protein response in disease. Nat Rev Drug Discov (2013) 3.37
Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression. Mol Cell Biol (2006) 3.31
Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science (2011) 3.29
Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci (2002) 3.28
Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology (1987) 3.11
Endoplasmic reticulum stress responses. Cell Mol Life Sci (2008) 3.11
Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses. Mol Cell Biol (2003) 3.01
Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2. Mol Cell Biol (2004) 3.00
The oligodendrocyte and its many cellular processes. Trends Cell Biol (1993) 2.91
Adaptive suppression of the ATF4-CHOP branch of the unfolded protein response by toll-like receptor signalling. Nat Cell Biol (2009) 2.42
Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat Rev Neurosci (2014) 2.25
The origin and application of experimental autoimmune encephalomyelitis. Nat Rev Immunol (2007) 2.19
Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Natl Acad Sci U S A (1992) 2.16
The impact of the endoplasmic reticulum protein-folding environment on cancer development. Nat Rev Cancer (2014) 2.04
Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron (1999) 2.00
Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in α-synucleinopathy in vivo. J Neurosci (2012) 1.95
The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron (2002) 1.91
Oligodendrocytes: biology and pathology. Acta Neuropathol (2009) 1.81
Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. Brain (2006) 1.78
Endoplasmic reticulum stress in disorders of myelinating cells. Nat Neurosci (2009) 1.76
The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J Clin Invest (2007) 1.74
Induction of liver steatosis and lipid droplet formation in ATF6alpha-knockout mice burdened with pharmacological endoplasmic reticulum stress. Mol Biol Cell (2010) 1.70
Myelin regeneration: a recapitulation of development? Annu Rev Neurosci (2011) 1.70
Myelination of the nervous system: mechanisms and functions. Annu Rev Cell Dev Biol (2014) 1.69
Endoplasmic reticulum stress modulates the response of myelinating oligodendrocytes to the immune cytokine interferon-gamma. J Cell Biol (2005) 1.69
Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders. J Cell Mol Med (2011) 1.68
Characterization of a novel PERK kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res (2013) 1.63
Anti-inflammatory properties of pro-inflammatory interferon-gamma. Int Immunopharmacol (2003) 1.62
ATF6alpha induces XBP1-independent expansion of the endoplasmic reticulum. J Cell Sci (2009) 1.57
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol (2010) 1.54
Pathology of demyelinating diseases. Annu Rev Pathol (2012) 1.52
IRE1: ER stress sensor and cell fate executor. Trends Cell Biol (2013) 1.48
Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid Redox Signal (2014) 1.47
Quantifying the early stages of remyelination following cuprizone-induced demyelination. Brain Pathol (2003) 1.47
Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci (1996) 1.42
The relevance of animal models in multiple sclerosis research. Pathophysiology (2011) 1.40
The unfolded protein response of B-lymphocytes: PERK-independent development of antibody-secreting cells. Mol Immunol (2007) 1.39
Translational regulation in the cellular response to biosynthetic load on the endoplasmic reticulum. Cold Spring Harb Symp Quant Biol (2001) 1.35
The effects of interferon-gamma on the central nervous system. Mol Neurobiol (1997) 1.35
Interferon-gamma induced medulloblastoma in the developing cerebellum. J Neurosci (2004) 1.35
Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis. J Immunol (2005) 1.34
Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models. Exp Neurol (2009) 1.33
Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis. Brain Pathol (2008) 1.32
Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. Ann Neurol (2009) 1.32
Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gamma. Am J Pathol (2008) 1.31
Getting RIDD of RNA: IRE1 in cell fate regulation. Trends Biochem Sci (2014) 1.30
Protein synthesis and its control in neuronal cells with a focus on vanishing white matter disease. Biochem Soc Trans (2009) 1.29
Oligodendrocytes and the early multiple sclerosis lesion. Ann Neurol (2012) 1.25
Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis. J Neurosci (2013) 1.22
In vitro and in vivo models of multiple sclerosis. CNS Neurol Disord Drug Targets (2012) 1.20
Multiple sclerosis - candidate mechanisms underlying CNS atrophy. Trends Neurosci (2010) 1.19
Building an antibody factory: a job for the unfolded protein response. Nat Immunol (2005) 1.17
Increased expression of endoplasmic reticulum stress-related signaling pathway molecules in multiple sclerosis lesions. J Neuropathol Exp Neurol (2008) 1.17
Control of NF-κB and inflammation by the unfolded protein response. Int Rev Immunol (2011) 1.16
Uncoupling proteostasis and development in vitro with a small molecule inhibitor of the pancreatic endoplasmic reticulum kinase, PERK. J Biol Chem (2012) 1.16
Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination. J Immunol (2010) 1.13
Interferon-gamma-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis. J Neurosci (2007) 1.10
Restoring endoplasmic reticulum homeostasis improves functional recovery after spinal cord injury. Neurobiol Dis (2013) 1.09
Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination. EMBO J (2000) 1.08
CHOP and the endoplasmic reticulum stress response in myelinating glia. Curr Opin Neurobiol (2009) 1.07
Neuroinflammation and endoplasmic reticulum stress are coregulated by crocin to prevent demyelination and neurodegeneration. J Immunol (2011) 1.05
Regional hypomyelination and dysplasia in transgenic mice with astrocyte-directed expression of interferon-gamma. J Mol Neurosci (2000) 1.05
T cells in the lesion of experimental autoimmune encephalomyelitis. Enrichment for reactivities to myelin basic protein and to heat shock proteins. J Clin Invest (1992) 1.05
Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination. Neurosci Res (2003) 1.03
A little stress is good: IFN-gamma, demyelination, and multiple sclerosis. J Clin Invest (2007) 1.03
NF-kappa B, a potential therapeutic target for the treatment of multiple sclerosis. CNS Neurol Disord Drug Targets (2008) 1.02
Endoplasmic reticulum: a metabolic compartment. FEBS Lett (2006) 1.01
PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases. Am J Pathol (2013) 1.00
Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic. Nat Commun (2015) 1.00